LTS Our TechnologiesLTS Our Technologies

OUR
TECHNOLOGIES

LTS Our TechnologiesLTS Our Technologies

OUR
TECHNOLOGIES

Innovative solutions for game changing therapies

Our partners want drug delivery solutions that add value to their innovations. Their patients want solutions that make their lives easier and healthier. At LTS we create innovative solutions that meet the needs of all – drive market value, address medical needs and improve patient outcomes.

Always looking forward, we are continuously improving our core TTS and OTF portfolio, while exploring emerging drug delivery technologies that will prove to become gamechangers.

Current indications include Alzheimer’s Disease, Contraceptives, Parkinson’s Disease, Hormone replacement therapy, Angina Pectoris, Opioid use disorder, Pain, Actinic keratosis and Nicotine addiction.

LTS Our Technologies

Always looking forward, we are continuously improving our core TTS and OTF portfolio, while exploring emerging drug delivery technologies that will prove to become gamechangers.

Current indications include Alzheimer’s Disease, Contraceptives, Parkinson’s Disease, Hormone replacement therapy, Angina, Pectoris, Opioid use disorder, Severe pain, Actinic keratosis and Nicotine addiction.

Our core technology portfolio

Transdermal Therapeutic Systems are applied to the skin and act systemically.

Transdermal Therapeutic Systems

LTS Technologies - TTS-Slider
Oral Thin Films are very thin polymer films taken orally, releasing active substances via the mucosa.

Oral Thin Films

LTS Technologies - OTF-Slider
Micro Array Patches comprise of tiny needles that penetrate into the uppermost dermal layer to release the active substance.

Micro Array Patches

LTS Technologies - MAP-Slider
A next generation on body delivery system (OBDS) for large volume and highly viscous formulations

Sorrel™ DEVICE TECHNOLOGY

LTS Technologies - TTS-Slider
TTS

Transdermal Therapeutic Systems  are applied to the skin and act systemically.

LTS Technologies - OTF-Slider
OTF

Oral Thin Films are very thin polymer films taken orally, releasing active substances via the mucosa.

LTS Technologies - MAP-Slider
MAP

Micro Array Patches comprise of tiny needles that penetrate into the uppermost dermal layer to release the active substance.

Sorrel

Sorrel™ DEVICE TECHNOLOGY

A next generation on body delivery system (OBDS) for large volume and highly viscous formulations